Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BiomX Inc. Director's Dealing 2022

Nov 15, 2022

35099_dirs_2022-11-14_7df0c6de-f7d5-4625-809d-edd81af3b62c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2022-10-17

Reporting Person: Ugwumba Chidozie (Exit Form 4 - former 10% owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-10-17 Common Stock S 8098 $0.335 Disposed 3063882 Indirect
2022-10-18 Common Stock S 15300 $0.346 Disposed 3048582 Indirect
2022-10-19 Common Stock S 4501 $0.367 Disposed 3044081 Indirect
2022-10-20 Common Stock S 6636 $0.374 Disposed 3037445 Indirect
2022-10-21 Common Stock S 5400 $0.37 Disposed 3032045 Indirect
2022-10-24 Common Stock S 5900 $0.349 Disposed 3026145 Indirect
2022-10-25 Common Stock S 3072 $0.365 Disposed 3023073 Indirect
2022-10-26 Common Stock S 12500 $0.346 Disposed 3010573 Indirect
2022-10-27 Common Stock S 1505 $0.364 Disposed 3009068 Indirect
2022-10-28 Common Stock S 1526 $0.356 Disposed 3007542 Indirect
2022-10-31 Common Stock S 3300 $0.371 Disposed 3004242 Indirect
2022-11-01 Common Stock S 1300 $0.364 Disposed 3002942 Indirect
2022-11-02 Common Stock S 2416 $0.359 Disposed 3000526 Indirect
2022-11-03 Common Stock S 2000 $0.366 Disposed 2998526 Indirect
2022-11-04 Common Stock S 1501 $0.378 Disposed 2997025 Indirect

Footnotes

F1: The shares are directly held by SymBiosis, LLC.